课题基金 / 基金详情

Basic study on chemotherapy combined with gene transfection for head and neck cancer

Basic study on chemotherapy combined with gene transfection for head and neck cancer
化疗联合基因转染治疗头颈癌的基础研究
批准号:
10470354
负责人:
SAITO Hitoshi
金额:
$4.42万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000

项目摘要

项目成果

SAITO Hitoshi的其他基金

相似基金

相关文献

中文摘要
翻译
139例头颈部肿瘤的ATP法化疗敏感率依次为5-FU (27%) >CDDP=CBDCA>MTX>PEP(23%)。因此,本研究的目的是联合转染与细胞凋亡相关的基因来克服化疗耐药。1998:在上述5种敏感药物中,由于CDDP是促进细胞凋亡的抗癌药物之一,我们选用CDDP进行进一步的研究。CDDP引起的细胞凋亡受谷胱甘肽和tunicamycin(一种糖基化抑制剂)调控。应用免疫组织化学方法研究了57例口咽鳞状细胞癌中Bax表达与5年生存率的关系。表达高促凋亡基因bax的患者5年生存率明显提高。1999: p53过表达预后明显差,而Bcl-2过表达与预后无相关性。经TUNEL染色,p53、Bax、Bcl-2的表达与细胞凋亡率无显著相关性,但Bax阳性组细胞凋亡倾向较高。由于高表达bax基因的临床病例预后较好,因此研究电穿孔转染bax基因的头颈癌细胞株和抗CDDP细胞株是否在体外对CDDP更敏感。转染bax的细胞系对CDDP的敏感性显著提高。表达bcl-2的肿瘤细胞系通过其反义表达明显提高CDDP敏感性。2000年:用一些促进细胞凋亡的基因进行化疗的体内研究。(1)研究促凋亡基因bax的抗癌作用及其与CDDP的联合作用。bax基因经皮颗粒传递(基因枪系统)可抑制小鼠抗cddp SCC的生长。此外,bax基因与CDDP每隔3天联合使用可显著抑制小鼠SCC的生长(p<0.0001)。(2)研究了caspase-activated DNase的抗癌作用及其与CDDP的联合作用。凋亡过程中最终的DNA片段是由CAD控制的。虽然基因枪单独传递CAD基因经皮转移没有明显的抑制作用,但CAD和CDDP联合使用可显著抑制SCC的生长(p<0.05)。(3)研究了Fas-Fas配体体系的抗致癌作用。由于C3H小鼠SCC不表达Fas配体,因此通过相同的基因枪将该配体递送到SCC中,并检测其抗癌作用。转染Fas配体的SCC生长受到显著抑制(p<0.0003),存活时间也显著延长。在上述3种促凋亡基因转染中,bax基因+CDDP的抗癌作用似乎最有效。少
英文摘要
The chemosensitive rate of 139 cases of head and neck cancer evaluated by ATP method was in the order of 5-FU (27%) >CDDP=CBDCA>MTX>PEP (23%). Therefore, the purpose of this study is to conquer the chemoresistance in combination with gene transfection relating to apoptosis.1998 : Among the above 5 sensitive drugs, CDDP was employed for the further study, because CDDP is one of the apoptosis-promoting anticancer drugs. Apoptosis by CDDP is regulated with glutathione and with tunicamycin, an inhibitor of glycosylation. A correlation between Bax expression and 5-year survival rate in 57 cases of oropharyngeal squamous cell carcinomas was investigated by immunohistochemical analysis. The cases expressed high apoptosis-promoting gene bax showed significantly better 5-year survival rate.1999 : Overexpression of p53 showed significantly poor prognosis, while that of Bcl-2 did not show any correlation to it. Correlation between the expressions of p53, Bax, Bcl-2 and apoptotic ratio evaluated b … More y TUNEL staining did not show significant relation, but Bax-positive group showed higher tendency to apoptosis. Since clinical cases highly expressed gene bax showed better prognosis, it was investigated whether the head and neck cancer cell line and CDDP-resistant cell line transfected gene bax by electroporation become more sensitive to CDDP in vitro. The cell lines transfected bax showed significantly higher sensitivity to CDDP.A cancer cell line expressing bcl-2 showed significantly increased CDDP sensitivity by its antisense.2000 : In vivo study on chemotherapy with some genes promoting apoptosis was carried out.(1) Anticancer effect of apoptosis-promoting bax gene and its combined effect with CDDP were investigated. Percutaneous transfer of bax gene by particle-mediated delivery (gene gun system) inhibited the growth of mouse CDDP-resistant SCC.Furthermore, a combination with bax gene and CDDP at 3-day intervals markedly inhibited the growth of mouse SCC (p<0.0001).(2) Anticancer effect of CAD (caspase-activated DNase) and its combined effect with CDDP were investigated. The final DNA fragmentation during apoptosis is controlled by CAD.Although percutaneous transfer of CAD gene alone delivered by the gene gun did not show clear inhibition, a combination with CAD and CDDP significantly inhibited the growth of SCC (p<0.05).(3) Anticanacer effect of Fas-Fas ligand system was investigated. Since the C3H mouse SCC did not express Fas ligand, this ligand was delivered into the SCC by the same gene gun, and examined the anticancer effect. The growth of SCC transfected Fas ligand was significantly inhibited (p<0.0003), and also significant elongation of the survival time was observed.Among the above 3 apoptosis-promoting gene transfections, the anticancer effect of bax gene +CDDP seemed to be most effective. Less
期刊论文(108)
专著(0)
科研奖励(0)
会议论文
Fujieda, S.: "CD40 stimulation inhibits cell growth and Fas-mediated apoptosis in a thyroid cancer cell line"Oncology Research. 10・. 433-439 (1998)
Fujieda, S.:“CD40 刺激抑制甲状腺癌细胞系中的细胞生长和 Fas 介导的细胞凋亡”Oncology Research 10·433-439 (1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
田中 信之: "頭頚部癌のCDDP耐性機序とその克服-GS-Xポンプによる薬剤排出とDNA修復能の亢進を中心に-"頭頚部腫瘍. 25・1. 153-158 (1999)
Nobuyuki Tanaka:“头颈癌中的 CDDP 耐药机制及其克服方法 - 重点关注 GS-X 泵增强药物流出和 DNA 修复能力”头颈肿瘤 25・1(1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Fujieda S: "Expression of Fas (CD95) ligand is correlated with IL-10 and granulocyte colony-stimulating factor expression in oral and oropharyngeal……"Cancer Lett. 161. 73-81 (2000)
Fujieda S:“Fas (CD95) 配体的表达与口腔和口咽中的 IL-10 和粒细胞集落刺激因子表达相关……”Cancer Lett。161. 73-81 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
38
    Development of near-field magnetic force microscopy for measuring absolute value of magnetic field and its application to high-resolution magnetic imaging of high performance permanent magnets
    • 批准号:
      25600092
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2013
    • 负责人:
      SAITO Hitoshi
    • 依托单位:
    Effect of typhoon frequency on landslide magnitude-frequency and sediment yield in temperate-humid and tectonically active region
    • 批准号:
      25882037
    • 项目类别:
      Grant-in-Aid for Research Activity Start-up
    • 资助金额:
      $1.75万
    • 财政年份:
      2013
    • 负责人:
      SAITO Hitoshi
    • 依托单位:
    High-resolution magnetic imaging of magnetic reversal for magnetic composite of nanoparticles by microwave assisted alternating magnetic force microscopy
    • 批准号:
      24360115
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.15万
    • 财政年份:
      2012
    • 负责人:
      SAITO Hitoshi
    • 依托单位:
    Development of high-resolution Near field magnetic force microscopy which enables to detect the direction and amplitude of static magnetic field near sample surface
    • 批准号:
      23656026
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.58万
    • 财政年份:
      2011
    • 负责人:
      SAITO Hitoshi
    • 依托单位:
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位:
    双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
    • 批准号:
      81670594
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2016
    • 负责人:
      陈昊
    • 依托单位:
    Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
    • 批准号:
      81470791
    • 项目类别:
      面上项目
    • 资助金额:
      73.0万元
    • 批准年份:
      2014
    • 负责人:
      董家鸿
    • 依托单位: